Thank you to UCB for this dinner!
Presentation Description: Please join us for an educational discussion around the role of IL17 in psoriatic disease and SpA, and potential mechanisms to mitigate it. This talk will take a deeper dive into the mechanisms of disease and understanding the various roles of IL17 in disease manifestation and management.
Speaker Bio: Dr. Chris Herrem, PhD is the Head of Medical Strategy – Rheumatology at UCB, Inc. He has spent the majority of his 22 year pharma career in Rheumatology Medical Affairs and holds a Ph.D. in Immunology from the University of Pittsburgh Medical School, as well as a B.S. in Genetics from the University of Wisconsin – Madison.